Analyst Ratings For Insulet
Portfolio Pulse from Benzinga Insights
Insulet (NASDAQ:PODD) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased by 8.69% to $252.89. Analysts have raised their price targets, reflecting positive sentiment. Insulet's financials show strong revenue growth, high net margin, and efficient asset utilization, but a high debt-to-equity ratio indicates financial risk.
October 14, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Insulet has received predominantly bullish analyst ratings, with an increase in the average price target to $252.89, indicating positive sentiment. The company's strong financial performance, including high revenue growth and net margin, supports this outlook, although its high debt-to-equity ratio poses a risk.
The majority of analysts have given bullish ratings to Insulet, with an increase in the average price target, reflecting positive sentiment. The company's strong financial metrics, such as revenue growth and net margin, further support a positive outlook. However, the high debt-to-equity ratio is a potential risk factor.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100